Harbour Capital Advisors, LLC Amgen Inc Transaction History

Harbour Capital Advisors, LLC

  • $415 Million
  • Q3 2024

A detailed history of Harbour Capital Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Harbour Capital Advisors, LLC holds 1,146 shares of AMGN stock, worth $337,531. This represents 0.09% of its overall portfolio holdings.

Number of Shares
1,146
Previous 1,146 -0.0%
Holding current value
$337,531
Previous $358,000 3.07%
% of portfolio
0.09%
Previous 0.09%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 16, 2024
BUY
$268.87 - $324.56 $15,325 - $18,499
57 Added 5.23%
1,146 $325,000
Q4 2023

Jan 05, 2024
SELL
$255.7 - $288.46 $6,392 - $7,211
-25 Reduced 2.24%
1,089 $313,000
Q3 2023

Oct 05, 2023
SELL
$218.65 - $271.46 $2,405 - $2,986
-11 Reduced 0.98%
1,114 $299,000
Q2 2023

Jul 10, 2023
SELL
$214.27 - $253.37 $4,071 - $4,814
-19 Reduced 1.66%
1,125 $249,000
Q1 2023

Apr 19, 2023
SELL
$225.79 - $275.2 $6,773 - $8,256
-30 Reduced 2.56%
1,144 $276,000
Q4 2022

Jan 13, 2023
SELL
$229.03 - $291.01 $11,451 - $14,550
-50 Reduced 4.08%
1,174 $0
Q2 2022

Jul 20, 2022
SELL
$230.71 - $256.74 $6,921 - $7,702
-30 Reduced 2.39%
1,224 $298,000
Q4 2021

Jan 12, 2022
SELL
$198.88 - $227.6 $9,944 - $11,380
-50 Reduced 3.83%
1,254 $282,000
Q3 2021

Oct 13, 2021
BUY
$212.27 - $248.7 $21,227 - $24,870
100 Added 8.31%
1,304 $277,000
Q1 2021

Apr 12, 2021
BUY
$221.91 - $258.6 $267,179 - $311,354
1,204 New
1,204 $299,000
Q4 2020

Jan 12, 2021
SELL
$216.38 - $257.67 $308,125 - $366,922
-1,424 Closed
0 $0
Q1 2020

Apr 08, 2020
SELL
$182.24 - $241.7 $3,644 - $4,834
-20 Reduced 1.39%
1,424 $289,000
Q3 2019

Oct 30, 2019
SELL
$174.11 - $208.62 $8,705 - $10,431
-50 Reduced 3.35%
1,444 $279,000
Q1 2019

Apr 24, 2019
SELL
$180.87 - $203.88 $6,330 - $7,135
-35 Reduced 2.29%
1,494 $284,000
Q4 2018

Jan 23, 2019
SELL
$178.4 - $208.25 $16,056 - $18,742
-90 Reduced 5.56%
1,529 $298,000
Q3 2018

Nov 07, 2018
SELL
$185.29 - $208.89 $2,779 - $3,133
-15 Reduced 0.92%
1,619 $336,000
Q2 2018

Jul 11, 2018
SELL
$166.05 - $186.51 $6,642 - $7,460
-40 Reduced 2.39%
1,634 $303,000
Q1 2018

Apr 18, 2018
SELL
$169.43 - $198.0 $17,790 - $20,790
-105 Reduced 5.9%
1,674 $285,000
Q4 2017

Jan 24, 2018
SELL
$168.79 - $188.59 $843 - $942
-5 Reduced 0.28%
1,779 $309,000
Q3 2017

Nov 08, 2017
BUY
$167.29 - $191.0 $298,445 - $340,744
1,784
1,784 $333,000

Others Institutions Holding AMGN

# of Institutions
3,122
Shares Held
410M
Call Options Held
7.56M
Put Options Held
7.2M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $158B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Harbour Capital Advisors, LLC Portfolio

Follow Harbour Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbour Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Harbour Capital Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email